Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic

Tian Lu; Yingrui Wang; Tiannan Guo

doi:10.1016/j.xcrm.2022.100580

Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic

Cell Rep Med. 2022 Mar 15;3(3):100580. doi: 10.1016/j.xcrm.2022.100580.

Authors

Tian Lu^{1

2

3}, Yingrui Wang^{1

2

3}, Tiannan Guo^{1

2

3}

Affiliations

¹ Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
² Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang Province, China.
³ Center for Infectious Disease Research, Westlake University, 18 Shilongshan Road, Hangzhou 310024, Zhejiang, China.

Abstract

COVID-19 is an ongoing pandemic of global concern and is unlikely to disappear. This commentary discusses how multi-omics technologies have helped uncover the molecular processes and dynamics underlying COVID-19 initiation, progression, and transmission, and how lack of standardization has limited their application in clinical settings.

Publication types

News
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Genomics*
Humans
Proteomics